Aim. The research of antimicrobial and toxicological parameters of a promising pharmaceutical composition with indole-3-carbinol and meloxicam in the form of rectal suppositories.
model of turpentine prostatitis [17] . The availability of the active components was determined by the degree of inhibition of inflammation and the effect on the hormonal background of the animals. Because PEO-based suppositories had a more pronounced effect on the course of the inflammatory process and reduced serum testosterone content, they were selected as a promising drug for further in-depth pharmacological research including the determination of acute toxicity and antimicrobial activity.
Aim of the research. Microbiological and toxicological study of a new preparation in the form of rectal polyethylene oxide-based suppositories (SCS-PEO) containing indole-3-carbinol and meloxicam.
Materials and methods
In the study of the antimicrobial properties of SCS-PEO, as the substances were used meloxicam (BoehringerIngelheimGmbH, Germany) and I3C (Sigma-Aldrich Co., USA), as well as samples of some variants of suppositories of the following composition:
- Microbiological study was performed on clinically significant pathogens of inflammatory diseases of the genitourinary system (including prostatitis). The reference strains of bacteria and fungi were taken from the Ukrainian Collection of Microorganisms of the Institute of Microbiology and Virology named after I. V. Zabolotnyi (Kyiv, Ukraine): Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 9027), Escherichia coli (ATCC 8739), Bacillus subtilis (ATCC 6633), Candida albicans (ATCC 10231).
The bacterial test strains were cultured at about 35 °C for 18 to 24 hours. on soybean casein agar. The studied C. albicans microorganism was grown on Saburo dextrose agar at a temperature of about 35 °C for 24 to 48 hours.
Before starting the experiment, the purity of each culture and its typical properties were checked for morphological, cultural and staining (for bacteria) characteristics.
A standard pharmacopoeial turbidity sample (PSS SPU) of 10 IU was used to prepare a microbial suspension of standard concentration [19] [20] [21] .
Studies on the specific antimicrobial action of the drug were performed in vitro by diffusion into nutrient agar with the modification of the wells in accordance with the recommendations [22] [23] [24] [25] .
Acute toxicity studies were performed with single administration of the maximum possible amount of the drug, since known maximum toxic doses for the active substances could not be achieved.
All experiments were carried out in accordance with the Law of Ukraine "On the Protection of Animals against Cruelty", which was agreed with the European Convention on the Protection of Vertebrate Animals of 1986 [26, 27] . Experiments were approved by the Bioethics Commission of the National University of Pharmacy (excerpt from protocol No. 3 of 20.04.2016).
Acute toxicity studies were conducted on 32 adult male rats randomized to 2 subgroups for oral and rectal administration of the study agent. Rats from subgroup 1 were injected intragastrically with a single dose of 4.5 g of SCS-PEO suppository, which corresponded to the administration of 10.75 mg meloxicam and 300 mg I3C per animal. Rats of subgroup 2, using a soft probe, performed rectal administration of the drug at a dose of 1 g, which corresponded to the administration of 2.5 mg meloxicam and 67.7 mg I3C per animal [18] .
Over the next 24 hours, the animals were continuously monitored for physiological parameters. From 1 to 14 days we carried out daily assessment of the animals. The animals were removed according to the scheme -4 animals from both subgroups after 1, 3, 7 and 14 days after the introduction of the studied SCS-PEO by rapid decapitation.
Physiological (measurement of basal body temperature, respiratory rate, monitoring of activity, feed and water consumption) and morphological parameters (body and organ weight, macroscopic morphological evaluation of internal organs) were used to evaluate toxicodynamics [28] .
Statistical processing of the results was carried out using software using variation statistics methods using parametric and non-parametric methods of analysis (Student and Mann-Whitney criteria) and presented as comparative tables with the results of different groups as arithmetic mean and its error (M±m) or Median and 25 and 75 percentile (Me, LQ; UQ). Differences were considered statistically significant at p<0.05 [29] .
Results
The results of a comparative study of the antimicrobial activity of suppository samples by agar diffusion ( Table 1 ) against reference strains of bacteria and fungi showed that Sample 1, which includes Montanox 80 and PEO-base, has no antimicrobial effect against B. subtilis (ATCC 6633), P. aeruginosa (ATCC 9027), S. aureus (ATCC 6538) and C. albicans (ATCC 10231). Small areas of inhibition of growth of E. coli (ATCC 8739) with a diameter of 13.27±0.36 mm were observed, indicating little antimicrobial activity against this bacterium.
Despite the absence of a well-described mechanism of antimicrobial activity, suppositories of I3C (Sample 2) showed antimicrobial action against all tested microorganisms used as reference. The most pronounced activity was observed for S. aureus -the area of inhibition of growth of S. aureus (ATCC 6538) was 38.60±0.99 mm, i. e., indicates a high level of antibacterial activity. High antibacterial activity was also observed in relation to gram-positive B. subtilis (ATCC 6633) -the diameter of the growth inhibition zone was 27.83±0.77 mm. Gram-negative bacteria showed moderate sensitivity to Sample 2, the diameter of the zone of inhibition of growth of E. coli and purulent sticks was less than 20 mm ( Table 1) . Concerning the strain of the yeast fungus C. albicans (ATCC 10231), Sample 2 showed a moderate antifungal effect -the diameter of the growth inhibition zone was 22.43±0.33 mm.
The severity of antibacterial and antifungal action of suppositories with I3C was not significantly dependent on the presence (Sample 5) or absence (Sample 2) of Montanox 80. The diameter of the growth inhibition zones of each of the studied organisms B. subtilis (ATCC 6633), E. coli (ATCC 8739), P. aeruginosa (ATCC 9027), S. aureus (ATCC 6538), and C. albicans (ATCC 10231) for Sample 5 did not differ significantly from the values obtained for Sample 2 ( Table 1) .
Suppositories with meloxicam (Sample 3) did not show antimicrobial activity against the microorganisms B. subtilis (ATCC 6633), P. aeruginosa (ATCC 9027), S. aureus (ATCC 6538) and C. albicans (ATCC 10231) -no growth inhibition zones were present. About E. coli (ATSC 8739) had poorly expressed activity -the diameter of the growth inhibition zone was significantly smaller than the diameter of the growth zones of E. coli for Sample 1. The antimicrobial activity of samples of suppositories containing I3C and meloxicam did not differ significantly from the activity of suppositories containing only I3C. It should be noted that there was a certain tendency to increase the degree of antibacterial activity in the presence of meloxicam in suppositories, but the difference in the diameters of growth inhibition zones was only significant in two cases -for Samples 2 and 4 for P. aeruginosa (ATCC 9027) and for Samples 5 and 6 regarding B. subtilis (ATCC 6633). In contrast, the antifungal activity of suppositories containing I3C and meloxicam against C. albicans (ATCC 10231) was significantly lower than that of suppositories containing I3C only.
After a single intragastric or rectal administration of the suppository mass of SCS-PEO, the animals remained alive on the first day and had normal appearance and behavior. In the future, at all times of observation, mobility, condition of the hair, open areas of the skin, eating behavior, excretion did not differ from the usual for laboratory rats. There were no unusual movements, tremors, and more. Body weight did not change statistically significantly over 14 days.
The results of the study of toxicodynamics by physiological (basal temperature, respiratory rate, observation of activity, feed and water consumption) and morphological (mass and macroscopic morphological evaluation of internal organs, determination of body weight and its changes) indicators in rats, which were once administered with suppository SCS-PEO shown in Fig. 1 . The data obtained during the first observation day every 6 h and in the following observation periods are presented: 3, 7 and 14 days. At the necropsy of animals at day 14, it was noted that the hair of the animals was soft and shiny, the natural ostium (eyes, mouth, ears, anus and penis) were dry, without secretions, the mucous membranes were shiny, pale pink. 
Medicine and Dentistry
The location, size, density, and colour of the thymus, heart, lungs, liver, spleen, kidneys, prostate, testes, and vesicles did not differ from these control animals. As shown in Table 2 , in all observation periods the mass coefficients of the organs have no significant differences with the reference indicators and in rats of both groups (oral and rectal administration) remained within the reference age norm [30] .
Macroscopic morphological examination revealed that 25 % of subgroups 1 (oral administration) rats withdrawn from the experiment at 24 h and 3 days showed gastric mucosa. This may be related to the effect of meloxicam, since inhibition of cyclooxygenase activity may slightly reduce the antacid protection of the gastric mucosa [31] .
It should be noted that the calculated therapeutic dose of the SCS-PEO suppository for meloxicam is 0.45 mg/kg, which, respectively, for rats weighing 200-220 g is a dose of 0.09-0.10 mg/kg. In our study, rats in subgroup 1 received oral meloxicam at a dose of 10.45 mg. Considering that the therapeutic dosage of the study drug was exceeded more than 100 times, the mucous membrane hyperaemia can be considered as an expected undesirable manifestation. Thus, SCS-PEO suppositories, which on the model of turpentine prostatitis showed a distinct prostate protective effect, showed antimicrobial properties against clinically significant agents of inflammation. In terms of toxicodynamics suppositories of the proposed composition can be considered a virtually non-toxic composition, which justifies the feasibility of further study of SCS-PEO as a promising prostate protector.
Discussion of the results
The absence of statistically significant differences of the studied indicators from the reference ones indicates that the degree of toxicodynamic effect of the combination of active components [32, 33] and the excipients [34] of SCS-PEO is consistent with the data reported in the literature. The results of the study on the parameters of acute toxicity indicate that SCS-PEO may be recommended for further preclinical study of specific prostate protective action, as significant toxic effects with single administration at doses exceeding the proposed therapeutic 3-4 times, were not detected. The proposed pharmaceutical composition based on polyethylene oxide based on the parameters of acute toxicity can be attributed to almost non-toxic substances.
Study limitations. The presence of antimicrobial activity in SCS-PEO suggests that there is both an additional therapeutic benefit (inhibitory effect on infectious prostatitis pathogens), and be a potential source of side effects (development of intestinal dysbiosis). The presence of meloxicam in suppositories does not significantly affect the antibacterial effect, but significantly reduces the antifungal activity of the pharmaceutical composition.
Prospects for further research. Given the potential risks of prolonged use, there is a need to consider further studies of SCS-PEO with the long-term introduction of cumulative toxic properties and adverse effects on the intestinal biotope.
Conclusions
The results show that suppositories with indole-3-carbinol and meloxicam meet the expected toxicity parameters. SCS-PEO suppositories exhibit a pronounced antibacterial effect against gram-positive and gram-negative bacteria and antifungal action. The revealed features of antimicrobial action make it possible to recommend the use of SCS-PEO for the treatment of not only aseptic but also bacterial (infectious) forms of prostatitis. Table 2 Original Research Article: full paper (2019), «EUREKA: Health Sciences» Number 5
Continuation of
Suppositories of the combination composition with indole-3-carbinol and meloxicam on a polyethylene oxide basis are a relatively safe preparation and may be recommended for further study of the specific pharmacological action.
